findmyKOL

Ravi Hira, MD

Basic profile

MultiCare Health System

ORCIDNPI
RegionSeattle, WA · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ravi Hira is a Cardiology physician affiliated with MultiCare Health System. OpenAlex indexes 110 publications with 1,601 citations (h-index 22).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
110publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,601citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
13companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

325 9th Ave
Seattle, WA 981042420

Telephone

206-744-3475

Registry record last updated 17 Sept 2015.

View the NPPES registry record

Industry payments

13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.9%
    Beta blocker20.6%
    Metoprolol Succinate77%Carvedilol20%Metoprolol Tartrate4%
    Part D<11 patients
    Statin20.4%
    Atorvastatin Calcium68%Rosuvastatin Calcium29%Pravastatin Sodium3%
    Part D<11 patients

    + 11 more classes in this area

  • Blood & clotting

    17.2%
    Factor Xa inhibitor10.3%
    Eliquis78%Xarelto22%
    Part D48 patients
    P2Y12 inhibitor6.9%
    Clopidogrel87%Brilinta13%
    Part D<11 patients
  • Metabolism & gastrointestinal

    2.9%
    SGLT2 inhibitor1.6%
    Farxiga69%Jardiance31%
    Part D<11 patients
    Potassium supplement0.7%
    Potassium Chloride100%
    Part D11 patients

    + 1 more class in this area

Where care is delivered (Part B)50.8% facility · 49.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”